Mentice AB (MNTC) - Total Assets
Based on the latest financial reports, Mentice AB (MNTC) holds total assets worth Skr299.56 Million SEK (≈ $32.24 Million USD) as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Explore how well can Mentice AB service its debt to assess how comfortably operating cash covers total debt obligations.
Mentice AB - Total Assets Trend (2017–2025)
This chart illustrates how Mentice AB's total assets have evolved over time, based on quarterly financial data. See MNTC net asset value for net asset value and shareholders' equity analysis.
Mentice AB - Asset Composition Analysis
Current Asset Composition (December 2025)
Mentice AB's total assets of Skr299.56 Million consist of 56.4% current assets and 43.6% non-current assets.
| Asset Category | Amount (SEK) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Skr0.00 | 10.7% |
| Accounts Receivable | Skr111.06 Million | 35.6% |
| Inventory | Skr17.76 Million | 5.7% |
| Property, Plant & Equipment | Skr0.00 | 0.0% |
| Intangible Assets | Skr59.31 Million | 19.0% |
| Goodwill | Skr48.51 Million | 15.6% |
Asset Composition Trend (2017–2025)
This chart illustrates how Mentice AB's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see how much is Mentice AB worth.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Mentice AB's current assets represent 56.4% of total assets in 2025, a decrease from 63.6% in 2017.
- Cash Position: Cash and equivalents constituted 10.7% of total assets in 2025, down from 15.7% in 2017.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 34.0% of total assets, an increase from 28.0% in 2017.
- Asset Diversification: The largest asset category is accounts receivable at 35.6% of total assets.
Mentice AB Competitors by Total Assets
Key competitors of Mentice AB based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Cochlear Ltd
AU:COH
|
Australia | AU$2.83 Billion |
|
COCHLEAR LTD ADR 1/2/O.N.
F:OC50
|
Germany | €2.83 Billion |
|
Novocure Ltd
NASDAQ:NVCR
|
USA | $787.93 Million |
|
Sinocare Inc
SHE:300298
|
China | CN¥6.25 Billion |
|
L&C Bio Co. Ltd
KQ:290650
|
Korea | ₩497.94 Billion |
|
Shanghai ZJ Bio-Tech Co. Ltd. A
SHG:688317
|
China | CN¥3.71 Billion |
|
Bactiguard Holding AB (publ)
ST:BACTI-B
|
Sweden | Skr537.34 Million |
|
Sequana Medical NV
BR:SEQUA
|
Belgium | €14.57 Million |
Mentice AB - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.99 | 0.86 | 1.03 |
| Quick Ratio | 0.89 | 0.75 | 0.96 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | Skr-1.97 Million | Skr-23.87 Million | Skr2.86 Million |
Mentice AB - Advanced Valuation Insights
This section examines the relationship between Mentice AB's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 3.42 |
| Latest Market Cap to Assets Ratio | 0.14 |
| Asset Growth Rate (YoY) | -3.7% |
| Total Assets | Skr312.02 Million |
| Market Capitalization | $43.89 Million USD |
Valuation Analysis
Below Book Valuation: The market values Mentice AB's assets below their book value (0.14x), which may indicate investor concerns about asset quality or future growth.
Slight Asset Contraction: Mentice AB's assets decreased by 3.7% over the past year, which may reflect streamlining or optimization of resources.
Annual Total Assets for Mentice AB (2017–2025)
The table below shows the annual total assets of Mentice AB from 2017 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | Skr312.02 Million ≈ $33.58 Million |
-3.67% |
| 2024-12-31 | Skr323.90 Million ≈ $34.86 Million |
+0.43% |
| 2023-12-31 | Skr322.53 Million ≈ $34.71 Million |
-3.14% |
| 2022-12-31 | Skr332.98 Million ≈ $35.83 Million |
+27.14% |
| 2021-12-31 | Skr261.90 Million ≈ $28.19 Million |
+6.78% |
| 2020-12-31 | Skr245.27 Million ≈ $26.40 Million |
+31.06% |
| 2019-12-31 | Skr187.14 Million ≈ $20.14 Million |
+43.31% |
| 2018-12-31 | Skr130.59 Million ≈ $14.05 Million |
+39.19% |
| 2017-12-31 | Skr93.82 Million ≈ $10.10 Million |
-- |
About Mentice AB
Mentice AB (publ), together with its subsidiaries, develops, sells, and markets solutions for training and decision support in the clinical area of interventional angiography in cardiology, neurology, vascular surgery, and radiology. It operates through the Mentice VIST, Physical Sim, and Ankyras segments. The company offers virtual simulation products, including VR simulator platforms; procedura… Read more